Richard A. Gonzalez
2016 - AbbVie
In 2016, Richard A. Gonzalez earned a total compensation of $21M as Chairman of the Board and Chief Executive Officer at AbbVie, a 1% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $3,232,531 |
|---|---|
| Non-Equity Incentive Plan | $3,600,000 |
| Option Awards | $2,360,323 |
| Salary | $1,600,000 |
| Stock Awards | $9,318,854 |
| Other | $859,216 |
| Total | $20,970,924 |
Gonzalez received $9.3M in stock awards, accounting for 44% of the total pay in 2016.
Gonzalez also received $3.2M of change in pension value and nonqualified deferred compensation earnings, $3.6M in non-equity incentive plan, $2.4M in option awards, $1.6M in salary and $859.2K in other compensation.
Rankings
In 2016, Richard A. Gonzalez's compensation ranked 105th out of 14,075 executives tracked by ExecPay. In other words, Gonzalez earned more than 99.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 105 out of 14,075 | 99th |
Division Manufacturing | 32 out of 5,488 | 99th |
Major group Chemicals And Allied Products | 9 out of 1,900 | 100th |
Industry group Drugs | 8 out of 1,543 | 100th |
Industry Pharmaceutical Preparations | 8 out of 1,173 | 99th |
Source: SEC filing on March 19, 2018.
Gonzalez's colleagues
We found four more compensation records of executives who worked with Richard A. Gonzalez at AbbVie in 2016.